We hypothesized that cognition and VEGF deficits were more pronounced in patients with non-remitted schizophrenia (NRS) as compared to healthy controls (HC) but not patients with remitted schizophrenia (RS), and that these abnormalities persisted even after remission of the patient’s psychiatric symptoms. Here, VEGFA is linked to schizophrenia.